Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
- Resource Type
- Article
- Source
- In
The Lancet Regional Health - Americas September 2023 25 - Subject
- Language
- ISSN
- 2667-193X